TAAR6 and psychiatric disorder: Thus, the pattern of TAAR6 expression in the brain, particularly in the areas involved in the pathogenesis of psychiatric disorders such as the frontal cortex and nucleus accumbens, supports previous genetic association studies and suggests that TAAR6 should be evaluated as a potential drug target to treat psychiatric disorders.